JOHN R. TREACE - 09 May 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for John R. Treace
Issuer symbol
TMCI
Transactions as of
09 May 2022
Transactions value $
-$1,050,676
Form type
4
Filing time
11 May 2022, 17:59:33 UTC
Previous filing
11 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale -$496K -37.3K -1.97% $13.30 1.86M 09 May 2022 John R. Treace and Ginger D. Treace JTTEN F1, F2
transaction TMCI Common Stock Sale -$269K -19K -1.02% $14.20 1.84M 09 May 2022 John R. Treace and Ginger D. Treace JTTEN F1, F3
transaction TMCI Common Stock Sale -$280K -18.4K -1% $15.22 1.82M 09 May 2022 John R. Treace and Ginger D. Treace JTTEN F1, F4
transaction TMCI Common Stock Sale -$4.9K -307 -0.02% $15.97 1.82M 09 May 2022 John R. Treace and Ginger D. Treace JTTEN F1, F5
holding TMCI Common Stock 409K 09 May 2022 As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021 F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.93 to $13.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.93 to $14.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.93 to $15.891 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.96 to $15.97 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The Reporting Person disclaims beneficial ownership of shares held in trusts for which his spouse is a co-trustee.